[AKRO] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
25-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -33.27%
YoY- -9.13%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -35,542 -27,403 -26,029 -32,424 -24,330 -28,933 -15,090 76.93%
Tax -549 297 -22 -11 -51 -50 -50 393.28%
NP -34,993 -27,403 -26,007 -32,424 -24,330 -28,933 -15,090 75.10%
Tax Rate - - - - - - - -
Total Cost 34,993 27,403 26,007 32,424 24,330 28,933 15,090 75.10%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.91 -0.77 -0.74 -0.93 -0.70 -0.83 -0.43 64.75%
EPS Diluted -0.91 -0.77 -0.74 -0.93 -0.70 -0.83 -0.43 64.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.